Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy

Authors: Sarika Jain, Ami N. Shah, Cesar A. Santa‐Maria, Kalliopi P. Siziopikou, Alfred Rademaker, Irene Helenowski, Massimo Cristofanilli, William J. Gradishar - Breast Cancer Research and Treatment 2018 cited by 152